Abstract
The obesity epidemic has evolved into an ever expanding serious global health concern. Several physiological as well as environmental factors have contributed to the rise in obesity incidence. Obesity or being overweight results from an energy imbalance characterized by an excess of caloric intake more often than not combined with a reduced energy expenditure, for example, due to physical inactivity. Nutrient status is communicated via circulating gut hormones, which all act on the brain to regulate short-and long-term appetite and the body’s metabolism and this brain-gut axis communication is dysregulated under metabolic conditions, such as obesity. Ghrelin is the only peripheral-derived hormone, which exerts an orexigenic effect via the modulation of central circuitries, and has therefore received considerable focus in the pharmaceutical industry for the development of anti-obesity therapeutics. Two subtypes of the ghrelin receptor have been reported to date, the growth hormone secretagogue (GHS-R1a) receptor 1a isoform, which is activated by acylated ghrelin, and the truncated isoform GHS-R1b, which is functionally inactive. Interestingly, the GHS-R1b receptor has been shown to exert a dominant-negative effect on GHS-R1a receptor functioning via the formation of a GHS-R1a/1b dimer. The GHS-R1a is expressed in multiple brain regions with ghrelin’s orexigenic effect on homeostatic food intake being mainly mediated in the arcuate nucleus of the hypothalamus and hedonic aspects being mediated via GHS-R1a receptors in the mesolimbic dopaminergic circuitry. In this review, we discuss the role of ghrelin in the hypothalamic regulation of appetite and highlight the additional dimension of the ghrelin/GHS-R1a receptor axis as a target in obesity via manipulation of the ghrelin-mediated nonhomeostatic rewarding aspect of food intake behavior. In addition, we review the current understanding of the role of the ghrelin receptor isoforms as targets in obesity and discuss the potential of heterodimers in the development of more specific anti-obesity therapeutics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abizaid A (2009) Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J Neuroendocrinol 21(9):787–793
Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschop MH, Gao XB, Horvath TL (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116(12):3229–3239
Adan RA, Tiesjema B, Hillebrand JJ, La Fleur SE, Kas MJ, Krom M de (2006) The MC4 receptor and control of appetite. Br J Pharmacol 149(7): 815–27
Ahima RS, Antwi DA (2008) Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am 37(4):811–823
Ahima RS, Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22(5):1023–1031
Andrews ZB (2011) Central mechanisms involved in the orexigenic actions of ghrelin. Peptides 32(11):2248–2255
Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschop MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao XB, Horvath TL, Diano S (2008) UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals. Nature 454(7206):846–851
Arnold M, Mura A, Langhans W, Geary N (2006) Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 26(43):11052–11060
Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52(7):947–952
Atalayer D, Gibson C, Konopacka A, Geliebter A (2013) Ghrelin and eating disorders. Prog Neuropsychopharmacol Biol Psychiatry 40:70–82
Banks WA, Tschop M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302(2):822–827
Banks WA, Burney BO, Robinson SM (2008) Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 29(11):2061–2065
Bassareo V, Di Chiara G (1999) Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89(3):637–641
Beck B, Richy S, Stricker-Krongrad A (2004) Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sci 76(4):473–478
Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, Warren VA, Howard AD, Van Der Ploeg LH, Heck JV (2000) Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43(23):4370–4376
Bing C, Ambye L, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA (2005) Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med 22(9):1157–1160
Blevins JE, Baskin DG (2010) Hypothalamic-brainstem circuits controlling eating. Forum Nutr 63:133–140
Bloom SR, Kuhajda FP, Laher I, Pi-Sunyer X, Ronnett GV, Tan TM, Weigle DS (2008) The obesity epidemic: pharmacological challenges. Mol Interv 8(2):82–98
Briggs DI, Enriori PJ, Lemus MB, Cowley MA, Andrews ZB (2010) Diet-Induced Obesity Causes Ghrelin Resistance in Arcuate NPY/AgRP Neurons. Endocrinology 151(10):4745–4755
Briggs DI, Lockie SH, Wu Q, Lemus MB, Stark R, Andrews ZB (2013) Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner. Endocrinology 154(2):709–717
Camina JP (2006) Cell biology of the ghrelin receptor. J Neuroendocrinol 18(1):65–76
Caminos JE, Gualillo O, Lago F, Otero M, Blanco M, Gallego R, Garcia-Caballero T, Goldring MB, Casanueva FF, Gomez-Reino JJ, Dieguez C (2005) The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 146(3):1285–1292
Casanueva FF, Camina JP, Carreira MC, Pazos Y, Varga JL, Schally AV (2008) Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc Natl Acad Sci USA 105(51):20452–20457
Castaneda TR, Tong J, Datta R, Culler M, Tschop MH (2010) Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 31(1):44–60
Center_for_Disease_Control (2013) “http://www.cdc.gov/obesity/data/databases.html“
Chakrabarti R (2009) Pharmacotherapy of obesity: emerging drugs and targets. Expert Opin Ther Targets 13(2):195–207
Chan CB, Cheng CH (2004) Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Mol Cell Endocrinol 214(1–2):81–95
Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Ploeg LH Van der, Howard AD, MacNeil DJ, Qian S (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145(6): 2607–2612
Cheng AY, Leiter LA (2006) Metabolic syndrome under fire: weighing in on the truth. Can J Cardiol 22(5):379–382
Chollet C, Meyer K, Beck-Sickinger AG (2009) Ghrelin–a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues. J Pept Sci 15(11):711–730
Chuang JC, Zigman JM (2010) Ghrelin’s roles in stress, mood, and anxiety regulation. Int J Pept
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337(9):581–588
Costantino L (2012) Growth hormone secretagogue receptor antagonists. Expert Opin Ther Pat 22(6):697–700
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37(4):649–661
Cummings DE, Shannon MH (2003) Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 138(4):389–396
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50(8):1714–1719
Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS (2002a) Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 8(7):643–644
Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002b) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346(21):1623–1630
Currie PJ, Mirza A, Fuld R, Park D, Vasselli JR (2005) Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei. Am J Physiol Regul Integr Comp Physiol 289(2):R353–R358
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141(11):4255–4261
DelParigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA (2002) High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab 87(12):5461–5464
Delporte C (2012) Recent advances in potential clinical application of ghrelin in obesity. J Obes 2012:535624
Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Berge G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J (2007) Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1. J Med Chem 50(8):1939–1957
Depoortere I (2009) Targeting the ghrelin receptor to regulate food intake. Regul Pept 156(1–3):13–23
Derosa G, Maffioli P (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11(3):459–471
Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E (2011) The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol 340(1):80–87
Disse E, Bussier AL, Veyrat-Durebex C, Deblon N, Pfluger PT, Tschop MH, Laville M, Rohner-Jeanrenaud F (2010) Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content. Physiol Behav 101(2):277–281
Disse E, Bussier AL, Deblon N, Pfluger PT, Tschop MH, Laville M, Rohner-Jeanrenaud F (2011) Systemic ghrelin and reward: effect of cholinergic blockade. Physiol Behav 102(5):481–484
Dostalova I, Haluzik M (2009) The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res 58(2):159–170
Douglas A, Douglas JG, Robertson CE, Munro JF (1983) Plasma phentermine levels, weight loss and side-effects. Int J Obes 7(6):591–595
Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C, Bloom SR (2005) Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 29(9):1130–1136
Egecioglu E, Jerlhag E, Salome N, Skibicka KP, Haage D, Bohlooly YM, Andersson D, Bjursell M, Perrissoud D, Engel JA, Dickson SL (2010) Ghrelin increases intake of rewarding food in rodents. Addict Biol 15(3):304–311
Egecioglu E, Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Jerlhag E, Engel JA, Dickson SL (2011) Hedonic and incentive signals for body weight control. Rev Endocr Metab Disord 12(3):141–151
Eknoyan G (2008) Adolphe Quetelet (1796-1874)–the average man and indices of obesity. Nephrol Dial Transplant 23(1):47–51
Esler WP, Rudolph J, Claus TH, Tang W, Barucci N, Brown SE, Bullock W, Daly M, Decarr L, Li Y, Milardo L, Molstad D, Zhu J, Gardell SJ, Livingston JN, Sweet LJ (2007) Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148(11):5175–5185
Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799
Faulconbridge LF, Cummings DE, Kaplan JM, Grill HJ (2003) Hyperphagic effects of brainstem ghrelin administration. Diabetes 52(9):2260–2265
Finger BC, Schellekens H, Dinan TG, Cryan JF (2011) Is there altered sensitivity to ghrelin-receptor ligands in leptin-deficient mice?: importance of satiety state and time of day. Psychopharmacology 216(3):421–429
Finger BC, Dinan TG, Cryan JF (2012) Diet-induced obesity blunts the behavioural effects of ghrelin: studies in a mouse-progressive ratio task. Psychopharmacology 220(1):173–181
Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497
Funahashi H, Takenoya F, Guan JL, Kageyama H, Yada T, Shioda S (2003) Hypothalamic neuronal networks and feeding-related peptides involved in the regulation of feeding. Anat Sci Int 78(3):123–138
Furness JB, Hunne B, Matsuda N, Yin L, Russo D, Kato I, Fujimiya M, Patterson M, McLeod J, Andrews ZB, Bron R (2011) Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 193:1–9
George SR, O’Dowd BF, Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1(10):808–820
Gibbs J, Young RC, Smith GP (1973) Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245(5424):323–325
Gualillo O, Lago F, Dieguez C (2008) Introducing GOAT: a target for obesity and anti-diabetic drugs? Trends Pharmacol Sci 29(8):398–401
Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Ploeg LH Van der, Howard AD (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48(1):23–29
Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 105(17):6320–6325
Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA (2010) Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol 6(5):255–269
Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, Yanovski JA, Purnell JQ, Freemark M (2008) Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 69(6):911–920
Hebert TE, Bouvier M (1998) Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem Cell Biol 76(1):1–11
Hinney A, Hoch A, Geller F, Schafer H, Siegfried W, Goldschmidt H, Remschmidt H, Hebebrand J (2002) Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab 87(6):2716
Hoebel BG (1985) Brain neurotransmitters in food and drug reward. Am J Clin Nutr 42(5 Suppl):1133–1150
Holliday ND, Holst B, Rodionova EA, Schwartz TW, Cox HM (2007) Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 21(12):3100–3112
Holst B, Schwartz TW (2004) Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 25(3):113–117
Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW (2003) High constitutive signaling of the ghrelin receptor–identification of a potent inverse agonist. Mol Endocrinol 17(11):2201–2210
Holst B, Brandt E, Bach A, Heding A, Schwartz TW (2005) Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol Endocrinol 19(9):2400–2411
Hosoda H, Kojima M, Matsuo H, Kangawa K (2000) Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275(29):21995–22000
Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K (2003) Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 278(1):64–70
Hou Z, Miao Y, Gao L, Pan H, Zhu S (2006) Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 134(2–3):126–131
Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273(5277):974–977
Inhoff T, Monnikes H, Noetzel S, Stengel A, Goebel M, Dinh QT, Riedl A, Bannert N, Wisser AS, Wiedenmann B, Klapp BF, Tache Y, Kobelt P (2008) Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 29(12):2159–2168
Inui A (2004) Ghrelin, obesity and anorexia nervosa. J Pediatr 145(6):862; author reply 862–823
Jeffery PL, Duncan RP, Yeh AH, Jaskolski RA, Hammond DS, Herington AC, Chopin LK (2005) Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology 146(1):432–440
Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12(1):6–16
Jiang H, Betancourt L, Smith RG (2006) Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 20(8):1772–1785
Kadowaki T, Yamauchi T, Kubota N (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582(1):74–80
Kageyama H, Kitamura Y, Hosono T, Kintaka Y, Seki M, Takenoya F, Hori Y, Nonaka N, Arata S, Shioda S (2008) Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice. Regul Pept 145(1–3):116–121
Kageyama K, Akimoto K, Yamagata S, Sugiyama A, Murasawa S, Watanuki Y, Tamasawa N, Suda T (2012) Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells. Regul Pept 174(1–3):12–17
Kang JG, Park CY (2012) Anti-Obesity drugs: a review about their effects and safety. Diabetes Metab J 36(1):13–25
Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396(6712):683–687
Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Bischoff-Grethe A (2013) Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci 36(2):110–120
Kent T, McAlpine C, Sabetnia S, Presland J (2007) G-protein-coupled receptor heterodimerization: assay technologies to clinical significance. Curr Opin Drug Discov Devel 10(5):580–589
Kern A, Albarran-Zeckler R, Walsh HE, Smith RG (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73(2):317–332
Kineman RD, Gahete MD, Luque RM (2007) Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J Mol Endocrinol 38(5):511–521
Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T (2003) Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52(4):948–956
Kojima M, Kangawa K (2002) Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2(6):665–668
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762):656–660
Kojima M, Hosoda H, Kangawa K (2001) Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm Res 56(Suppl 1):93–97
Kojima M, Hosoda H, Kangawa K (2004) Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 18(4):517–530
Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits M (2005) Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 280(26):25196–25201
Konturek SJ, Konturek JW, Pawlik T, Brzozowski T (2004) Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55(1 Pt 2):137–154
Korbonits M, Gueorguiev M, O’Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P (2002) A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 87(8):4005–4008
Koyama KI, Yasuhara D, Nakahara T, Harada T, Uehara M, Ushikai M, Asakawa A, Inui A (2010) Changes in acyl ghrelin, des-acyl ghrelin, and ratio of acyl ghrelin to total ghrelin with short-term refeeding in female inpatients with restricting-type anorexia nervosa. Horm Metab Res 42(8):595–598
Krsek M, Rosicka M, Papezova H, Krizova J, Kotrlikova E, Haluz’k M, Justova V, Lacinova Z, Jarkovska Z (2003) Plasma ghrelin levels and malnutrition: a comparison of two etiologies. Eat Weight Disord 8(3):207–211
Kurose Y, Iqbal J, Rao A, Murata Y, Hasegawa Y, Terashima Y, Kojima M, Kangawa K, Clarke IJ (2005) Changes in expression of the genes for the leptin receptor and the growth hormone-releasing peptide/ghrelin receptor in the hypothalamic arcuate nucleus with long-term manipulation of adiposity by dietary means. J Neuroendocrinol 17(6):331–340
Larsen LH, Gjesing AP, Sorensen TI, Hamid YH, Echwald SM, Toubro S, Black E, Astrup A, Hansen T, Pedersen O (2005) Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clin Biochem 38(5):420–424
Lawrence CB, Snape AC, Baudoin FM, Luckman SM (2002) Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143(1):155–162
le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR (2005) Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 90(2):1068–1071
Leite-Moreira AF, Soares JB (2007) Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 12(7–8):276–288
Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH, Wise H (2007) The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 19(5):1011–1022
Liu G, Fortin JP, Beinborn M, Kopin AS (2007) Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities. J Pharmacol Exp Ther 322(3):1036–1043
Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, Date Y, Nakazato M, Kojima M, Kangawa K, Shioda S (2002) Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321(3):157–160
Lu SC, Xu J, Chinookoswong N, Liu S, Steavenson S, Gegg C, Brankow D, Lindberg R, Veniant M, Gu W (2009) An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Mol Pharmacol 75(4):901–907
Luttrell LM (2008) Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol Biotechnol 39(3):239–264
Lutz TA (2006) Amylinergic control of food intake. Physiol Behav 89(4):465–471
Mager U, Degenhardt T, Pulkkinen L, Kolehmainen M, Tolppanen AM, Lindstrom J, Eriksson JG, Carlberg C, Tuomilehto J, Uusitupa M (2008) Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance. PLoS ONE 3(8):e2941
Marston OJ, Garfield AS, Heisler LK (2011) Role of central serotonin and melanocortin systems in the control of energy balance. Eur J Pharmacol 660(1):70–79
Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, Di Blasio A, Liuzzi A (2004) The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 89(2):936–939
Matsumoto M, Hosoda H, Kitajima Y, Morozumi N, Minamitake Y, Tanaka S, Matsuo H, Kojima M, Hayashi Y, Kangawa K (2001a) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 287(1):142–146
Matsumoto M, Kitajima Y, Iwanami T, Hayashi Y, Tanaka S, Minamitake Y, Hosoda H, Kojima M, Matsuo H, Kangawa K (2001b) Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues. Biochem Biophys Res Commun 284(3):655–659
Melis MR, Mascia MS, Succu S, Torsello A, Muller EE, Deghenghi R, Argiolas A (2002) Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection. Neurosci Lett 329(3):339–343
Mikhail N (2009) The metabolic syndrome: insulin resistance. Curr Hypertens Rep 11(2):156–158
Miwa H, Koseki J, Oshima T, Kondo T, Tomita T, Watari J, Matsumoto T, Hattori T, Kubota K, Iizuka S (2010) Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa. J Gastroenterol 45(5):478–487
Montoya-Flores D, Mora O, Tamariz E, Gonzalez-Davalos L, Gonzalez-Gallardo A, Antaramian A, Shimada A, Varela-Echavarria A, Romano-Munoz JL (2012) Ghrelin stimulates myogenic differentiation in a mouse muscle satellite cell line and in primary cultures of bovine myoblasts. J Anim Physiol Anim Nutr (Berl) 96(4):725–738
Moreira FA, Crippa JA (2009) The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr 31(2):145–153
Moulin A, Ryan J, Martinez J, Fehrentz JA (2007) Recent developments in ghrelin receptor ligands. ChemMedChem 2(9):1242–1259
Moulin A, Demange L, Ryan J, M’Kadmi C, Galleyrand JC, Martinez J, Fehrentz JA (2008a) Trisubstituted 1, 2, 4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3. Bioorg Med Chem Lett 18(1):164–168
Moulin A, Demange L, Ryan J, Mousseaux D, Sanchez P, Berge G, Gagne D, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J (2008b) New trisubstituted 1, 2, 4-triazole derivatives as potent ghrelin receptor antagonists 3. Synthesis and pharmacological in vitro and in vivo evaluations. J Med Chem 51(3):689–693
Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E (2007) Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 86(3):147–164
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409(6817):194–198
Naleid AM, Grace MK, Cummings DE, Levine AS (2005) Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26(11):2274–2279
Narayanan NS, Guarnieri DJ, DiLeone RJ (2010) Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol 31(1):104–112
Nass R, Gaylinn BD, Thorner MO (2011) The ghrelin axis in disease: potential therapeutic indications. Mol Cell Endocrinol 340(1):106–110
Nathan PJ, O’Neill BV, Napolitano A, Bullmore ET (2011) Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neurosci Ther 17(5):490–505
Nguyen N, Champion JK, Ponce J, Quebbemann B, Patterson E, Pham B, Raum W, Buchwald JN, Segato G, Favretti F (2012) A review of unmet needs in obesity management. Obes Surg 22(6):956–966
Nishi Y, Hiejima H, Hosoda H, Kaiya H, Mori K, Fukue Y, Yanase T, Nawata H, Kangawa K, Kojima M (2005) Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146(5):2255–2264
Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307(5):483–490
Ogiso K, Asakawa A, Amitani H, Inui A (2011) Ghrelin and anorexia nervosa: a psychosomatic perspective. Nutrition 27(10):988–993
Ohgusu H, Shirouzu K, Nakamura Y, Nakashima Y, Ida T, Sato T, Kojima M (2009) Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Biochem Biophys Res Commun 386(1):153–158
Olszewski PK, Grace MK, Billington CJ, Levine AS (2003a) Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 24(6):919–923
Olszewski PK, Li D, Grace MK, Billington CJ, Kotz CM, Levine AS (2003b) Neural basis of orexigenic effects of ghrelin acting within lateral hypothalamus. Peptides 24(4):597–602
Overduin J, Figlewicz DP, Bennett-Jay J, Kittleson S, Cummings DE (2012) Ghrelin increases the motivation to eat, but does not alter food palatability. Am J Physiol Regul Integr Comp Physiol 303(3):R259–R269
Pandit R, de Jong JW, Vanderschuren LJ, Adan RA (2011) Neurobiology of overeating and obesity: the role of melanocortins and beyond. Eur J Pharmacol 660(1):28–42
Panetta R, Greenwood MT (2008) Physiological relevance of GPCR oligomerization and its impact on drug discovery. Drug Discov Today 13(23–24):1059–1066
Parylak SL, Koob GF, Zorrilla EP (2011) The dark side of food addiction. Physiol Behav 104(1):149–156
Patterson M, Murphy KG, le Roux CW, Ghatei MA, Bloom SR (2005) Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 90(4):2205–2211
Patterson M, Bloom SR, Gardiner JV (2011) Ghrelin and appetite control in humans–potential application in the treatment of obesity. Peptides 32(11):2290–2294
Perello M, Zigman JM (2012) The role of ghrelin in reward-based eating. Biol Psychiatry 72(5):347–353
Perello M, Sakata I, Birnbaum S, Chuang JC, Osborne-Lawrence S, Rovinsky SA, Woloszyn J, Yanagisawa M, Lutter M, Zigman JM (2010) Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry 67(9):880–886
Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, Stricker-Krongrad A (2004) Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord 28(7):879–885
Pfluger PT, Kirchner H, Gunnel S, Schrott B, Perez-Tilve D, Fu S, Benoit SC, Horvath T, Joost HG, Wortley KE, Sleeman MW, Tschop MH (2008) Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am J Physiol Gastrointest Liver Physiol 294(3):G610–G618
Powell AG, Apovian CM, Aronne LJ (2011) New drug targets for the treatment of obesity. Clin Pharmacol Ther 90(1):40–51
Rediger A, Tarnow P, Bickenbach A, Schaefer M, Krude H, Grüters A, Biebermann H (2009) Heterodimerization of Hypothalamic G-Protein-Coupled receptors involved in weight regulation. Obes Facts 2(2):80–86
Rediger A, Piechowski CL, Yi CX, Tarnow P, Strotmann R, Gruters A, Krude H, Schoneberg T, Tschop MH, Kleinau G, Biebermann H (2011) Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem 286(45):39623–39631
Richardson NR, Gratton A (1998) Changes in medial prefrontal cortical dopamine levels associated with response-contingent food reward: an electrochemical study in rat. J Neurosci 18(21):9130–9138
Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, Raimondo F, Cocchi D, Solcia E (2002) Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol 117(6):511–519
Rodriguez A, Gomez-Ambrosi J, Catalan V, Gil MJ, Becerril S, Sainz N, Silva C, Salvador J, Colina I, Fruhbeck G (2009) Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) 33(5):541–552
Rozenfeld R, Devi LA (2010) Receptor heteromerization and drug discovery. Trends Pharmacol Sci 31(3):124–130
Rozenfeld R, Devi LA (2011) Exploring a role for heteromerization in GPCR signalling specificity. Biochem J 433(1):11–18
Rudolph J, Esler WP, O’Connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH (2007) Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J Med Chem 50(21):5202–5216
Sakata I, Nakamura K, Yamazaki M, Matsubara M, Hayashi Y, Kangawa K, Sakai T (2002) Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 23(3):531–536
Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, McAllister G, Guest PC (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277(18):15482–15485
Sato T, Fukue Y, Teranishi H, Yoshida Y, Kojima M (2005) Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology 146(6):2510–2516
Schellekens H, Dinan TG, Cryan JF (2009) Lean mean fat reducing “ghrelin” machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 58(1):2–16
Schellekens H, Finger BC, Dinan TG, Cryan JF (2012) Ghrelin signalling and obesity: at the interface of stress, mood and food reward. Pharmacol Ther 135(3):316–326
Schellekens H, Dinan TG, Cryan JF (2013a) Ghrelin at the interface of obesity and reward. Vitam Horm 91:285–323
Schellekens H, Dinan TG, Cryan JF (2013b) Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward. Frontiers Neurosci 7
Schellekens H, van Oeffelen WE, Dinan TG, Cryan JF (2013c) Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem 288(1):181–191
Seim I, Collet C, Herington AC, Chopin LK (2007) Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genom 8:298
Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87(1):240–244
Shimbara T, Mondal MS, Kawagoe T, Toshinai K, Koda S, Yamaguchi H, Date Y, Nakazato M (2004) Central administration of ghrelin preferentially enhances fat ingestion. Neurosci Lett 369(1):75–79
Shrestha YB, Wickwire K, Giraudo S (2009) Effect of reducing hypothalamic ghrelin receptor gene expression on energy balance. Peptides 30(7):1336–1341
Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I (2002) Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109(11):1429–1436
Simpson K, Martin A, Niamh M, Bloom SR (2008) Hypothalamic regulation of appetite. Expert Rev Endocrinol Metab 3(5):577–592
Simpson KA, Martin NM, Bloom SR (2009) Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol 53(2):120–128
Skibicka KP, Dickson SL (2011) Ghrelin and food reward: the story of potential underlying substrates. Peptides 32(11):2265–2273
Skibicka KP, Hansson C, Egecioglu E, Dickson SL (2012) Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict Biol 17(1):95–107
Smith NJ, Milligan G (2010) Allostery at G protein-coupled receptor homo-and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62(4):701–725
Soares JB, Leite-Moreira AF (2008) Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 29(7):1255–1270
Soares JB, Roncon-Albuquerque R Jr, Leite-Moreira A (2008) Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity. Expert Opin Ther Targets 12(9):1177–1189
Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J (2004) Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr 144(1):36–42
Stanley S, Wynne K, McGowan B, Bloom S (2005) Hormonal regulation of food intake. Physiol Rev 85(4):1131–1158
Stengel A, Goebel M, Wang L, Tache Y (2010) Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 31(2):357–369
Stricker-Krongrad A, Richy S, Beck B (2002) Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul Pept 104(1–3):11–20
Sun Y, Ahmed S, Smith RG (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23(22):7973–7981
Sun Y, Wang P, Zheng H, Smith RG (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101(13):4679–4684
Sun Y, Butte NF, Garcia JM, Smith RG (2008) Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology 149(2):843–850
Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR (2010) The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 57(5):359–372
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL (2011) The global obesity pandemic: shaped by global drivers and local environments. The Lancet 378(9793):804–814
Tamura H, Kamegai J, Shimizu T, Ishii S, Sugihara H, Oikawa S (2002) Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 143(9):3268–3275
Tanaka M, Hayashida Y, Nakao N, Nakai N, Nakashima K (2001) Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim Biophys Acta 1522(1):62–65
Teitler M, Klein MT (2012) A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivo. Pharmacol Ther 133(2):205–217
Terrillon S, Bouvier M (2004) Roles of G-protein-coupled receptor dimerization. EMBO Rep 5(1):30–34
Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89(23):1763–1773
Tolle V, Low MJ (2008) In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Diabetes 57(1):86–94
Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, Shioda S, Matsukura S, Kangawa K, Nakazato M (2003) Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144(4):1506–1512
Tovar S, Nogueiras R, Tung LY, Castaneda TR, Vazquez MJ, Morris A, Williams LM, Dickson SL, Dieguez C (2005) Central administration of resistin promotes short-term satiety in rats. Eur J Endocrinol 153(3):R1–R5
Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C (2001a) Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24(6):RC19–RC21
Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407(6806):908–913
Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001b) Circulating ghrelin levels are decreased in human obesity. Diabetes 50(4):707–709
Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, Bouchard C (2001) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab 86(8):3996–3999
Venkova K, Greenwood-Van Meerveld B (2008) Application of ghrelin to gastrointestinal diseases. Curr Opin Investig Drugs 9(10):1103–1107
Vivenza D, Rapa A, Castellino N, Bellone S, Petri A, Vacca G, Aimaretti G, Broglio F, Bona G (2004) Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol 151(1):127–133
Volkow ND, Wang GJ, Baler RD (2010) Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 15(1):37–46
Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R, Carter CS, Dalley JW (2012) Food and drug reward: overlapping circuits in human obesity and addiction. Brain imaging in behavioral neuroscience; current topics in behavioral neuroscience, vol 11. Springer, Berlin, pp 1–24
Wise RA (2006) Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361(1471):1149–1158
Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225
World_Health_Organisation (2013) http://www.who.int/topics/obesity/en/index.html
Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, Wiegand SJ, Sleeman MW (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101(21):8227–8232
Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW (2005) Absence of ghrelin protects against early-onset obesity. J Clin Invest 115(12):3573–3578
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86(12):5992–5995
Xu Y, Elmquist JK, Fukuda M (2011) Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci 1243:1–14
Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami K, Sugiyama F, Goto K, Yanagisawa M, Sakurai T (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38(5):701–713
Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL (2008a) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132(3):387–396
Yang J, Zhao TJ, Goldstein JL, Brown MS (2008b) Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides. Proc Natl Acad Sci U S A 105(31):10750–10755
Yi CX, Heppner K, Tschop MH (2011) Ghrelin in eating disorders. Mol Cell Endocrinol 340(1):29–34
Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J (2004) Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 101(28):10434–10439
Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC (2010) Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity. Bioorg Med Chem Lett 20(5):1758–1762
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432
Zhi J, Melia AT, Eggers H, Joly R, Patel IH (1995) Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol 35(11):1103–1108
Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115(12):3564–3572
Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494(3):528–548
Zorrilla EP, Iwasaki S, Moss JA, Chang J, Otsuji J, Inoue K, Meijler MM, Janda KD (2006) Vaccination against weight gain. Proc Natl Acad Sci USA 103(35):13226–13231
Acknowledgements
The work was supported by Enterprise Ireland under Grant Number CC20080001. JFC and TGD are also supported in part by Science Foundation Ireland (SFI) in the form of a center grant (Alimentary Pharmabiotic Center) through the Irish Government’s National Development Plan. The authors and their work were supported by SFI (grant no.s 02/CE/B124 and 07/CE/B1368). JFC is funded by European Community’s Seventh Framework Program; Grant Number: FP7/2007-2013, Grant Agreement 201714.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schellekens, H., Dinan, T.G., Cryan, J.F. (2014). The Ghrelin Receptor: A Novel Therapeutic Target for Obesity. In: Portelli, J., Smolders, I. (eds) Central Functions of the Ghrelin Receptor. The Receptors, vol 25. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0823-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0823-3_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0822-6
Online ISBN: 978-1-4939-0823-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)